Skip to main content
. 2022 Oct 28;130(10):107003. doi: 10.1289/EHP10605

Table 5.

Hazard ratios (95% CIs) for site-specific cancers by years of PCB exposure with combined exposure categories due to small number of cases adjusted for age, sex, and time period (n=38,613 Danish residents).

Cancer site (ICD-10) Continuous Nonexposed 0–2.9 y >2.9 y
Cases (n) HR (95% CI) Cases (n) HR (95% CI) Cases (n) HR (95% CI) Cases (n) HR (95% CI)
Rectum (C20) 111 1.01 (0.95, 1.07) 85 1.00 10 0.60 (0.31, 1.16) 16 1.41 (0.82, 2.42)
Liver (C22) 40 1.08 (1.02, 1.15) 25 1.00 7 1.48 (0.64, 3.43) 8 2.45 (1.10, 5.45)
Corpus uteri (C54–55, C58)a 70 1.03 (0.97, 1.09) 53 1.00 7 0.69 (0.31, 1.51) 10 1.27 (0.64, 2.52)
Ovary, fallopian tube, and broad ligament (C56, C570–C574)a 73 1.00 (0.93, 1.09) 60 1.00 7 0.60 (0.28, 1.32) 6 0.74 (0.32, 1.72)
Kidney (C64) 86 1.01 (0.94, 1.09) 65 1.00 14 1.11 (0.62, 1.97) 7 0.93 (0.42, 2.03)
Meningiomas (C70, D32, D42) 53 1.06 (1.00, 1.12) 32 1.00 7 1.14 (0.50, 2.58) 14 3.19 (1.69, 6.02)

Note: CI, confidence interval; HR, hazard ratio; ICD-10, International Statistical Classification of Diseases and Related Health Problems, 10th Revision.

aRestricted to female population.